Nunes, Estevão P <br/><br/>
Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study).  [electronic resource] 

 -  HIV clinical trials   
 - 368-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-4336 
<br/><br/><label>Standard No.: </label>10.1310/hct1006-368  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>CD4 Lymphocyte Count<br/>Drug Combinations<br/>Drug Resistance, Viral--genetics<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--administration & dosage<br/>HIV-1--drug effects<br/>Humans<br/>Lopinavir<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Pyrimidinones--administration & dosage<br/>Ritonavir--administration & dosage<br/>Semen--virology<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load--drug effects